University of Texas Rio Grande Valley

ScholarWorks @ UTRGV
School of Medicine Publications and
Presentations

School of Medicine

2020

HYPOTHETICAL HUMAN IMMUNE GENOME COMPLEX
GRADIENT MAY HELP TO EXPLAIN THE CONGENITAL ZIKA
SYMDROME CATASTROPHE IN BRAZIL: A NEW THEORY
F. R. S. Oliveira
C. C. Bresani-Salvi
C. N. L. Morais
A. W. Bigham
U. Braga-Neto

See next page for additional authors

Follow this and additional works at: https://scholarworks.utrgv.edu/som_pub
Part of the Medicine and Health Sciences Commons

Recommended Citation
Oliveira, F. R. S., Bresani-Salvi, C. C., Morais, C. N. L., Bigham, A. W., Braga-Neto, U., Maestre, G. E.,
Wandebergh, J. L., Marques, E. T. A., & Acioli-Santos, B. (2020). Hypothetical Human Immune Genome
Complex Gradient May Help to Explain the Congenital Zika Symdrome Catastrophe in Brazil: A New
Theory. BioRxiv, 2020.06.03.132878. https://doi.org/10.1101/2020.06.03.132878

This Article is brought to you for free and open access by the School of Medicine at ScholarWorks @ UTRGV. It has
been accepted for inclusion in School of Medicine Publications and Presentations by an authorized administrator
of ScholarWorks @ UTRGV. For more information, please contact justin.white@utrgv.edu,
william.flores01@utrgv.edu.

Authors
F. R. S. Oliveira, C. C. Bresani-Salvi, C. N. L. Morais, A. W. Bigham, U. Braga-Neto, Gladys E. Maestre, John
L. VandeBerg, E. T. A. Marques, and B. Acioli-Santos

This article is available at ScholarWorks @ UTRGV: https://scholarworks.utrgv.edu/som_pub/92

HYPOTHETICAL HUMAN IMMUNE GENOME COMPLEX GRADIENT MAY HELP TO EXPLAIN THE
CONGENITAL ZIKA SYMDROME CATASTROPHE IN BRAZIL: A NEW THEORY
Oliveira F.R.S1, Bresani-Salvi C.C. 2, Morais C. N.L. 2, Bigham A.W. 3, Braga-Neto U.4, Maestre G.E. 5, 6,
Wandebergh j. l. 6, 7, 8, Marques E.T.A9, and Acioli-Santos B. 2*
1

Federal Institute of Science and Education of Pernambuco (IFPE), Paulista, PE, Brazil. 2Department of

Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ), Recife, PE, Brazil.
3

Department of Anthropology, University of California, LA, USA. 4 Department of Electrical and Computer

Engineering, Texas A&M University, College Station,TX, USA. 5 Department of Neuroscience, School of
Medicine, The University of Texas Rio Grande Valley, Brownsville/Harlingen/Edinburg, TX, USA.
6

Department Human Genetics, School of Medicine, The University of Texas Rio Grande Valley,

Brownsville/Harlingen/Edinburg, TX, USA. 7 South Texas Diabetes and Obesity Institute, School of
Medicine, The University of Texas Rio Grande Valley, Brownsville/Harlingen/Edinburg, TX, USA. 8 Center
of Vector-Borne Diseases, The University of Texas Rio Grande Valley, Brownsville/Harlingen/Edinburg,
TX, USA. 9 Department of Infectious Diseases and Microbiology, Graduate School of Public Health,
University of Pittsburgh, PA. USA. *Corresponding author. Email: bartacioli@cpqam.fiocruz.br

Runing title: CZS immune complex gradient
Keywords: CZS, genome markers, immune complex genome gradient

ABSTRACT
There are few data considering human genetics as an important risk factor for birth
abnormalities related to ZIKV infection during pregnancy, even though sub-Saharan African
populations are apparently more resistant to CZS as compared to populations in the Americas.
We hypothesized that single nucleotide variants (SNVs), especially in innate immune genes,
could make some populations more susceptible to Zika congenital complications than others.
Differences in the SNV frequencies among continental populations provide great potential for
Machine Learning techniques. We explored a key immune genomic gradient between
individuals from Africa, Asia and Latin America, working with complex signatures, using 297
SNVs. We employed a two-step approach. In the first step, decision trees (DTs) were used to
extract the most discriminating SNVs among populations. In the second step, machine learning
algorithms were used to evaluate the quality of the SNV pool identified in step one for
discriminating between individuals from sub-Saharan African and Latin-American populations.
Our results suggest that 10 SNVs from 10 genes (CLEC4M, CD58, OAS2, CD80, VEPH1, CTLA4,
CD274, CD209, PLAAT4, CREB3L1) were able to discriminate sub-Saharan Africans from Latin
American populations using only immune genome data, with an accuracy close to 100%.
Moreover, we found that these SNVs form a genome gradient across the three main continental
populations. These SNVs are important elements of the innate immune system and in the
response against viruses. Our data support the Human Immune Genome Complex Gradient
hypothesis as a new theory that may help to explain the CZS catastrophe in Brazil.

INTRODUCTION
Zika virus (ZIKV), an arbovirus that belongs to the Flaviviridae family, was initially
isolated from a captive rhesus monkey in Uganda in 1947 (Dick et al. 1952; Dick et al. 1953). The
most common reported ZIKV infection symptoms in humans are rash, fever, arthralgia, and

conjunctivitis. Most patients experience only a mild and transitory illness, but severe neurologic
complications have been described (Loos et al. 2014). ZIKV is predominantly transmitted by
Aedes sp. mosquito species such as A. aegypti and A. albopictus, which also are vectors of
dengue virus (DENV) and chikungunya virus (CHIKV). Laboratory diagnosis of ZIKV infection is
based on IgG/IgM ELISA, and detection of viral RNA in the blood, serum or other body fluids
(amniotic fluid, saliva, urine, semen), and/or viral isolation (Bachiller-Luque et al. 2016; Duffy et
al. 2009). However, because of the co-circulation of arboviruses such as DENV and CHIKV, and
cross-reactive antibodies, ZIKV infections are sometime missed or incorrectly diagnosed (Oehler
et al. 2014).
In 2007, the first Zika epidemic occurred on the Yap Islands, an island chain in the
Federated States of Micronesia. In 2013, a new epidemic started in French Polynesia (Musso et
al. 2014), when it was observed a 20-fol increase in the incidence of Guillain-Barré syndrome
(GBS), an immune mediated ascending flaccid paralysis (Oehler et al. 2014). In Brazil, ZIKV was
first identified in 2015 in the State of Bahia in patients with clinical symptoms similar to those of
dengue fever (Campos et al. 2015; Pinto Junior et al. 2015). These initial cases in Bahia were
followed by epidemics in other northeastern states of Brazil. In the second half of 2015, there
was a significant increase of newborns with microcephaly and other birth abnormalities in
Northeastern Brazil, with 2,366 cases of microcephaly and other birth defects being reported by
December of 2016, particularly in the State of Pernambuco (Schuler-Faccini et al. 2016). In Latin
America, 1.6 million cases of ZIKV infections occurred between 2015 and 2016, followed by
thousands of cases of microcephaly (WHO 2017; Oliveira et al. 2017).
The dramatic increase in the incidence of microcephaly concomitant with the ZIKV
epidemic in Brazil alerted the scientific community to a potential causal association, leading the
Brazilian Ministry of Health to declare the ZIKV epidemic to be a “national public health
emergency”; and then, the World Health Organization (WHO) to declarate it to be a "public

health emergency of international concern" (Albuquerque et al. 2018). Retrospective
observational studies reinforced the suspicion of a causal of ZIKV infection with microcephaly
(Araújo et al. 2018; Brasil et al. 2016; Cauchemez et al. 2016), and with non-congenital
neuroinflammatory diseases, such GBS, encephalitis and myelitis (Cao-Lormeau et al. 2016;
Parra et al. 2016; Styczynski et al. 2017; Salinas et al. 2017; Mehta et al. 2018). Several reports
where instrumental in establishing the association between ZIKV and microcephaly. Mlakar et
al. (2016) identified ZIKV in the brain tissue of a severe microcephalic stillbirth whose mother
had been infected with ZIKV in Brazil. This report was one of first to propose the possibility of
an association between ZIKV and microcephaly, which was later confirmed by case-control
studies with Brazilian newborns (MERG Group 2016; Cordeiro et al. 2016; Brasil et al. 2016;
Krow-Lucal et al. 2018).
Based on this literature, microcephaly combined with other fetal abnormalities
associated with congenital ZIKV infection, in addition to microcephaly, have earned their own
name: Congenital Zika Syndrome (CZS) (Miranda-Filho et al. 2016). Since then, CZS has been
reported at variable frequencies in different investigations of pregnant women infected with
ZIKV. Honein et al. (2017), studying 442 pregnancies with laboratory evidence of recent ZIKV
infection in US territories, reported a 6% incidence of CZS including 18 cases of microcephaly
(4%). In the case-control study by Hoen et al. (2018), in the French territories in the Americas,
7% of fetuses and infants of 527 ZIKV-PCR positive women were born with CZS, among which 32
(6%) had microcephaly. In turn, Brasil et al. (2016) had reported a very high frequency of 42% of
CZS in infants born to 117 ZIKV-PCR positive woman from Rio de Janeiro in Southeastern Brazil,
among which there were four babies with microcephaly (3.4%). It is noteworthy that this
Brazilian case-control study applied an expanded CZS criterion, including children with tenuous
and unspecific findings on MRI scans (Brasil et al. 2016).

These variations may be related, in part, to differences in the CZS/microcephaly
diagnostic criteria, but variation in CZS risk could also explain these disparities. Furthermore,
striking differences in incidence of microcephaly were observed in different regions of Brazil, the
country with the most extensive ZIKV epidemic. More than 75% of the Brazilian cases of
microcephaly were from the Northeast region, where the monthly incidence reached many
times the incidence of the Southern population: 50 versus 1.5 per 10,000 live births (Oliveira et
al. 2017). Accordingly, Barbeito-Andrés et al. (2018) suggested that cofactors, such as ZIKV
strains, and environmental and human genetic variations, could potentially explain the
geographic clustering of microcephaly in the Northeast of Brazil. They further showed an
association between the incidence of microcephaly and the states with the highest prevalence
of undernutrition (Barbeito-Andrés et al. 2020).
Studies in mice identified highly susceptible as well as resistant mouse strains as relevant
models to access the mechanisms of ZIKV infection. Manet et al. (2020) showed that
susceptibility was driven by multiple loci with small individual effects, and was independent of
the Oas1b gene, which functions in the innate antiviral immunity pathway. Another recent
animal study showed differences in inoculation routes influencing the rate of infection and viral
load in mouse embryos (Duggal et al. 2018). These models reflect the role of host diversity on
ZIKV infection outcome and highlight the need for additional studies in humans to address the
role of different cofactors involved in CZS (Barbeito-Andrés et al. 2018). Genetic data related to
human CZS are rare, in part due to difficulties in developing well-controlled case-control studies.
Nonetheless, one revealing study found that discordant CZS twins have differential in vitro viral
susceptibility of neural progenitor cells, expressing MTOR and WNT regulatory genes differently;
both genes are part of key pathways in programming neural embryology (Caires-Junior et al.
2018). Case-control studies have shown the influence of maternal adenocyclase (ADCY) SNVs
(Rossi et al. 2019) and of TOL3 (maternal)/TNFα (infants) SNVs (Santos et al. 2019) in
susceptibility of CZS and/or microcephaly. In turn, Azamor et al. (2018) indicated that a Type III

interferon maternal SNV promotes protection against the development of CZS. Taken together,
these data indicate that host genetic background related to antiviral responses, especially
against arboviruses, may affect the outcome of fetal ZIKV infection.
Human genetic risk factors could be key elements in ZIKV-mother and ZIKV-baby
interactions, as they might influence the vertical transmission of the virus, cell and tissue
damage, and consequent congenital abnormalities associated with the ZIKV infection. However,
the frequency of relevant alleles may not be uniformly distributed across global populations. In
fact, population genetic differences likely arose during the evolution that occurred during the
dispersion of Homo sapiens from Africa to other continents roughly 100,000 years ago. This
dispersion led to selection of a series of genetic adaptations under different climatic and other
environmental conditions, including food sources and local pathogens, leading to population
differentiation. This differentiation, in turn, led to continuous gradients of genomic variants
(Serre and Paabo 2004), including gradients of various resistance/susceptibility alleles for
infectious diseases (Karlsson et al. 2014). We hypothesize that alleles at a number of loci in genes
that influence immunity, interacting in a complex manner, may drive differences in the balance
between resistance and susceptibility to CZS, forming a geographic genomic gradient of host
susceptibility.
To test our hypothesis, we applied a methodologic approach that is pioneering in both
method and concept. We developed a new tool based on SNV allele frequencies in several genes
involved in immune function, evaluated together in a complex manner by machine learning
techniques. Based on data from previous outbreaks of ZIKV, we hypothesized that sub-Saharan
Africans were resistant to CZS and that Latin Americans were susceptible, these are the two
populations that represent the theoretical extremes for risk of CZS epidemics. Our dual decision
tree (DT)/trained machine learning models were able to distinguish individuals from Africa and
the Americas with an accuracy of 98% using only ten SNVs from ten genes involved in immune

functions (CLEC4M / CD299, CD58, OAS2, CD80, VEPH1, CTLA4, CD274, CD209, PLAAT4,
CREB3L1). Here, we present the Human Immune Genome Complex Gradient Theory as potential
explanation of why the CZS catastrophe occurred in Brazil.

RESULTS
We developed five dual DT/machine learning classification pipelines (e.g. DT/SVM
linear) exclusively with immune SNVs in genes involved in immune functions, aiming to detect a
potential allele frequency gradient across sub-Saharan African, East Asian, and Latin American
populations, and to determine if it was consistent with the CZS risks in ZIKV-infected women
among these continents. The analysis of the SNVs (hypothetical candidates features) resulted in
a set of ten SNVs from ten genes involved in immune functions: CLEC4M/CD299, CD58, OAS2,
CD80, VEPH1, CTLA4, CD274, CD209, PLAAT4, and CREB3L1, which together displayed high
power to discriminate between sub-Saharan Africans and Latin Americans. This selected SNV set
provided high accuracy with all five dual DT/ML techniques (Fig. 1). The confusion matrices, ROC
Curves, and other metrics suggest that this immune response SNV set is indeed a reliable
discriminator of the two populations, which are theoretically at the extremes of risk for CZS.

Fig. 1. Statistical metrics (confusion matrix, classification metrics, ROC curve) for all five tested dual DT/ML
genome approaches for immune genome discrimination between sub-Saharan African and Latin American
populations: DT/Linear regression, DT/KNN, DT/DT, DT/SVM Linear, DT/SVM Kernel.

Figure 2 displays our Human Immune Genome Complex Gradient Theory as an
infographic. Briefly, our dual DT/trained machine learning models, using the immune genome
complex approach, revealed a unique and robust tool comprising ten SNVs acting in an
integrated manner to discriminate sub-Saharan African and Latin American populations (Figure
2-A). For six of the ten SNVs, VEPH1/rs3911403-T, CREB3L1/rs7127254-C, PLAAT4/rs4963271-A,
CD58/rs1335531-G, CD80/rs2629396-G, and OAS2/rs15895-A, the reference allele increased in
frequency from sub-Saharan Africa to Latin America (Figure 2-B). In contrast,
CLEC4M/rs12610506-G, CD274/rs4143815-G, and CD209/rs4804801-T decreased in frequency
from sub-Saharan Africa to Latin America, while CTLA4/rs41265961-G was virtually constant. In
addition to differences in host genetic variation at these ten SNPs, the circulating ZIKV lineage
differed by continent (Figure 2-C) (Liu et al. 2019). Similarly, risk estimates of microcephaly in
infants born to women infected with ZIKV during pregnancy differed by continent (Figure 2-D)
(Cauchemez et al. 2016; Oliveira et al. 2017).

FIG. 2. Machine learning approach and genetic CZS/microcephaly hypothesis overview. A) Genotype
based Support Vector Machine (SVM) approach (second round) used for sub-Saharan African/Latin
American population discrimination using only immune gene data pre-selected by DT, with ten SNVs and
the hyperplane separation stage. B) Reference allele frequencies of the ten selected SNV/gene candidates
for CZS phenotype predisposition in South America, showing allele frequency differences between subSaharan Africans and Latin Americans. C) ZIKV lineage circulating in each continent (*Asian Lineages are
classified according to amino acid pattern at three positions: 139 in prM, 982 in NS1 and 2634 in NS5) (Liu
et al. 2019). D) Probability of microcephaly in babies born to ZIKV-infected mothers during epidemics on
the three continents (1Cauchemez et al. 2016; 2Oliveira et al. 2017).

Allele frequencies of the ten selected SNVs are shown for each 1000 Genomes
continental (Table 1).

Table 1. Allele frequencies of ten selected SNVs in the DT/SVM complex immune genome tool among subSaharan African, East Asian, and Latin American populations from the 1000 Genomes.

rsID
rs1335531
rs41265961
rs2629396
rs3911403
rs4143815
rs7127254
rs4963271
rs15895
rs4804801

Gene
CD58
CTLA4
CD80
VEPH1
CD274
CREB3L1
PLAAT4
OAS2
CD209

Chr:Position
(HG38)
1:116572755
2:203871138
3:119530120
3:157444338
9:5468257
11:46286998
11:63537712
12:113010483
19:7742596

rs12610506

CLEC4M/CD299

19:7768185

Allelesα
G/C
G/A
G/T
T/A
G/C
C/T
A/G
A/G
T/A

sub-Saharan
Africans
(661)
0.10
0.99
0.06
0.47
0.98
0.29
0.23
0.01
0.67

East
Asians
(347)
0.92
1.00
0.37
0.80
0.42
0.85
0.72
0.00
0.40

Latin
Americans
(489)
0.76
0.99
0.43
0.92
0.57
0.83
0.83
0.22
0.11

G/A

0.98

0.84

0.58

α

The reference allele is listed first followed by the non-reference allele. All population allele frequencies
are provided for the reference allele

DISCUSSION
CZS epidemiology
The CZS epidemic is recent and peaked in an epidemiological crisis in Brazil in 2015,
becoming a more widespread geographic problem in 2016. Several reports were important to
establish the causal link between ZIKV and microcephaly and other congenital malformations,
which together became known as CZS. In recent CZS literature, there have been significant
advances in our understanding of ZIKV epidemiology and evolution. This report presents a
hypothesis to explain the high level of ZIKV teratovirulence and the high incidence of CZS cases
in South America, especially in Brazil.
As of January 2017, 2,635 cases of central nervous system malformation potentially
associated with ZIKV had been reported around the world, among which 2,366 were from Brazil
and 78 were from Colombia (WHO 2017). Furthermore, although ZIKV might be widespread
across Africa, reports of CZS cases in Africa are rare (WHO 2017; Hill et al. 2019). This dichotomy

is not likely to be the consequence of differences in rate of ZIKV infection among pregnant
women from different epidemic regions. A meta-analysis by Coelho et al. (2017), including
observational studies, found a high inter-study variability in the frequencies of microcephaly in
infants born to ZIKV-infected women, ranging from zero to 14%. This variability may be due to
differences in the case definition of ZIKV infection and CZS between studies. However, some
population-based estimates indicate that the risk of microcephaly may be different among ZIKVinfected pregnant women from different populations (Pacheco et al. 2016; Cauchemez et al.
2016; Oliveira et al. 2017; Barbeito-Andrés et al. 2020).
During the ZIKV outbreak in French Polynesia (2013-2014), only eight cases of
microcephaly occurred, resulting in a risk of 0.95% among women infected in the first trimester
of pregnancy (Cauchemez et al. 2016). Impressively, 1,950 cases of infection-related
microcephaly were confirmed after ZIKV epidemics in Brazil (2015-2016), reaching an incidence
of 4.5% in babies born to infected woman (Oliveira et al. 2017). It is important to highlight that,
in the Brazilian epidemics (2015-2016), 31,000 ZIKV suspected cases were reported to the
surveillance systems, but it is estimated that 1,673,272 persons were infected with ZIKV (Oliveira
et al. 2017). Similarly, in the Polynesian epidemic 31,000 persons were estimated to have been
infected, but only 8,000 cases of ZIKV infections were officially reported (Cauchemez et al. 2016).
Although we cannot account in our analysis for the under-reporting in our consideration of the
incidence of CZS, there were strikingly different risks even within Brazil, the country with the
most extensive ZIKV epidemics. More than 75% of the Brazilian cases of microcephaly were from
the Northeast region, where the monthly incidence reached several times the incidence of
Southern population: 50 versus 1.5 per 10,000 live births (Oliveira et al. 2017). In turn, an
ecological study at a municipality level across Brazil was unable to correlate the incidence of
microcephaly with the incidence of ZIKV infection, but this showed a correlation with poverty
index. These data suggested that ZIKV might not be, alone, be responsible for the unusual
pattern of microcephaly in Brazil that clustered in the Northeast region (Campos et al. 2018).

Some hypotheses have emerged to explain the asymmetrical distribution of CZS risk and
ZIKV neurovirulence. The evolution of ZIKV strains, vector competence of mosquitoes across
continents, climatic conditions, environmental toxins, and nutritional factors deserve to be
considered.

In

turn,

immunological

and

genetic

variability

influencing

the

susceptibility/resistance status of the human host is also worthy of concern, especially in ZIKV
naïve areas where DENV has been hyper-endemic, as pre-infection with DENV might lead to an
antibody enhancement response that induces the severest clinical outcomes (Zhong-Yu et al.
2019; Barbeito-Andrés et al. 2020). To date, there is a single ZIKV serotype, but two major viral
lineages (African and Asian) have been identified through phylogenetic analyses. The Asian
lineage can be divided into two subclades (Asian and Contemporary American), which are
responsible for the recent outbreaks and are associated with clinical severity in the Pacific region
and the Americas, respectively (Liu et al. 2019). Some experimental studies based on reverse
genetics have shown that ZIKV undergoes genetic changes over time and that amino acid
mutation patterns in ZIKV surface proteins may have contributed to the epidemic waves that
occurred in Micronesia (2007), French Polynesia (2013-2014), and South America (2015-2016)
(Faria et al. 2017; Metsky et al. 2017). Among the genetic changes, three important amino acid
mutations, respectively, in prM S139N (substitution of Serine to Asparagine at position 139),
NS1 A928V (substitution of Alanine to Valine), and NS5 M/T2634V (substitution of Methionine
or Threonine to Valine), have been related to a more neurovirulent and pathogenic ZIKV strain
spreading from Asia to the Americas (Zhong-Yu et al. 2019) (Fig. 1). An increase in neurovirulence
and pathogenic capacity of ZIKV as it spread to the Americas may have been a contributing
factor, together with the host genetic factors that we propose, to the CZS catastrophe in Brazil.
Among environmental cofactors, contaminants in the water supplies, pre-natal vaccines,
and the use of alcohol, cigarettes, or drugs during pregnancy were all considered as potential
contributing factors to the Brazilian cluster of microcephaly at the beginning of epidemic. In the
first case-control study proving the association of microcephaly with ZIKV in Pernambuco (OR=

73; CI 13-∞), neither vaccination during pregnancy or use of drugs, alcohol, or larvicides, were
associated with microcephaly (Araújo et al. 2018). However, smoking was found to be associated
with microcephaly (Araújo et al. 2018). Similarly, an ecological study found no correlation
between the use of the larvicide pyriproxyfen in stored water and microcephaly among
municipalities of the metropolitan region of Pernambuco, the epicenter of the Brazilian
microcephaly epidemic (Albuquerque et al. 2016). Interestingly, experiments in mouse models
suggested that maternal diet protein restriction (Barbeito-Andrés et al. 2020) and exposure to
cyanobacterial saxitoxin through water intake (Pedrosa et al. 2019) exacerbate brain
malformations induced by ZIKV. In fact, CZS may have multiple environmental cofactors and may
be influenced by ZIKV genetic factors, but the constellation of alleles of host genes involved in
immune functions may also be important predictor of the occurrence and severity of CZS.

CZS genetics and the hypothetical Human Immune Genome Complex Gradient
Genetic data pertinent to CZS are rare due the difficulties in recruiting human CZS
cohorts into well-controlled CZS case-control studies. Developing such studies is particularly
challenging given the difficulties associated with diagnostic certainty of congenital ZIKVinfection as well as ascertaining the embryonic or fetal period of infection. In fact, not a single
well-controlled genomic study was conducted with the hundreds of children with CZS during the
Brazilian epidemics. However, genetic studies using animal models can shed light on the role of
different cofactors involved in CZS. IFN I receptor gene (IfnarI) knockout mice and the use of
anti-IFNAR antibody in vivo showed that CZS susceptibility was driven by multiple loci with small
individual effects and independent of the Oas1b gene (Manet et al. 2020). These results indicate
that novel experimental models of infection can help to address the role of different cofactors
and genes involved in CZS.

Given the paucity of genetic data from human ZIKV case-control association studies, and
combined with evidence from animal models demonstrating the impact of host genetic factors
on the development of CZS, we are presenting a new theory to help explain the Brazilian CZS
catastrophe of 2015-2016: the Human Immune Genome Complex Gradient hypothesis. Our
analysis of global allele frequency data from 297 immune response genes across three
continental populations suggest that, at the population level, sub-Saharan Africans are quite
resistant to CZS, East Asians are moderately susceptible, and Latin Americans are highly
susceptible to CZS. The rationale is based on ten key SNPs in immune functional genes, whose
alleles collectively discriminate among three populations, creating a combined signature for
each, and forming a hypothetical geographical gradient for risk of CZS. The genes exhibiting
these SNPs (CLEC4M / CD299, CD58, OAS2, CD80, VEPH1, CTLA4, CD274, CD209, PLAAT4,
CREB3L1) are important for function of innate immune system and for anti-viral response. We
posit that, in a complex manner, the constellation of SNVs in these genes can potentially
influence ZIKV vertical transmission, tissue damage, and congenital abnormalities; and
consequently, the outcome of ZIKV-mother and ZIKV-fetus interactions.
We advocate that an immune genome gradient is probably developed as consequence
of host-pathogen co-evolution during H. sapiens dispersion across continents thousands of years
ago. Modern humans appeared in Africa about 200,000 years ago, dispersed to Asia
approximately 100,000 years ago, and subsequently colonized the rest of the world in a series
of migratory events. During these events, humans encountered a wide range of different
environmental conditions, such as climate, food availability, and local pathogens (Fumagalli et
al. 2011). These environmental differences probably selected for genetic adaptations and
resulted in the establishment of continuous genome gradients of allele frequencies across
populations (Serre and Paabo 2004; Marian 2009).

For infectious diseases, natural selection in human populations is evident for pathogens
with a long-standing relationship with H. sapiens, including those that cause malaria, smallpox,
cholera, tuberculosis, and leprosy (Karlsson et al. 2014). The timing, strength and direction of
selection (that is, positive, negative, or balancing) shape the patterns of genomic variation
(Karlsson et al. 2014). Hence, mutations in immune-inflammatory response genes are good
candidates for understanding why some populations are more susceptible to infections than
others. For example, in models of human genome adaptations, approaches that consider a single
pathogen have provided examples of host evolution driven by the influence of that pathogen.
The case of anemia falciform is a classic example. In heterozygosity, the sickle cell allele confers
sickle cell trait and protection against Falciparum malaria, while in homozygotes it is life
threatening; and so a sickle cell trait occurs at a high frequency in malaria-rich regions, such as
Africa, and at a low frequency outside of these regions (Kwiatkowski 2005). Another inherited
red blood cell disorder that is associated with malaria resistance is caused by glucose-6phosphate dehydrogenase (G6PD) deficiency, which also coincides with the geographical
distribution of malaria (Tishkoff et al. 2001).
Many other instances of population level differences in infectious disease susceptibility
have been described. For example, MHC complex (HLA) diversity confers differential resistance
to a wide range of pathogens (Buhler and Sanchez-Mazas 2011), and has been demonstrated to
impact the clinical course of infection for a large number of viral infectious diseases including
dengue fever (Stephens et al. 2010), yellow fever (Co et al. 2002), and hepatitis C Virus (HCV)
(Kuniholm et al. 2011). Genetic variation in toll like receptor genes suggests that Europeans
exhibit a reduced TLR1-mediated response compared to other global populations (Barreiro et
al. 2009). Another example, African Americans are more likely than Caucasians to carry cytokine
variants that up-regulate pro-inflammatory responses (Ness et al. 2004). This may predispose
individuals of African ancestry to higher rates of inflammatory diseases (Ness et al. 2004).
Similarly, Pennington et al. (2009) suggested that African populations from tropical Africa have

a more robust inflammatory response compared to Europeans and East Asians. They
hypothesized that this robust response was the result of variation in immune response genes
that evolved in response to local pathogen exposure: parasites with low virulence and long lifespans such as those that cause malaria in Africa versus high-virulence pathogens such as those
that cause smallpox and cause measles in Europe and East Asia. Taken together, these are
emblematic examples demonstrating that human genetic variation contributes to differences in
response to infections, and they support our hypothesis that a complex genome gradient has
contributed to CZS phenotype distribution across global populations.
There have been studies that examined the impact of immune genetic factors impact on
CZS. Hamel et al. (2015) carried out an in vitro gene expression study on ZIKV infection in
epidermal cells, and demonstrated that receptors such as DC-SIGN, TIM-1, TIM-4, AXL, and TIROL
are important elements for ZIKV entry into cells. They observed significant reduction in the
percentage of ZIKV-infected cells when the AXL receptor is blocked by antibodies, and similarly
for DENV-infected cells. The ZIKV-infected fibroblasts presented expression of anti-viral
response genes, cell receptors genes, and immunity genes. Up-regulation of many genes
involved in immune response has also already been observed in models of DENV infection, such
as FAAD, IFN, MYD88 (Gomes et al. 2010), OAS, PYCARD, TNF (Nascimento et al. 2009), and STAT
(Warke et al. 2003), supporting the idea of common key elements for both flaviviruses. In
humans, case-control immune genome studies have shown the influence of maternal
adenocyclase SNV (Rossi et al. 2018) and TOL3 (maternal)/TNFα (infants) (Santos et al. 2019) on
CZS susceptibility or severe microcephaly. On the other hand, Azamor et al. (2018) indicated that
a maternal IFN III SNV promotes protection against the development of CZS. However, to date,
there are no reports regarding influence of a combination of genotypes at multiple loci/genes
on the risk for CZS.

The immune genome SNV tool
Our dual DT/ML immune genome approach showed that allele frequencies of ten SNPs
of ten genes are consistent with the risk of microcephaly across Africa, French Polynesia, and
Brazil, and may have contributed to the Brazilian CZS epidemics. All of these genes (CLEC4M,
CD58, OAS2, CD80, VEPH1, CTLA4, CD274, CD209, PLAAT4, CREB3L1) are involved with innate
immune response, virus cycle, or anti-virus response. Seven of those polymorphisms are genic
SNPs (six are “transcript variants” and one is “stop codon lost”), rather than in non-genic
sequence. Our results agree with Fumagalli et al. (2011) who found a significant enrichment of
genic SNPs, in particular non-synonymous SNPs vs intergenic SNPs, involved in local adaptation
to pathogenic exposure across human populations. As Karlsson et al. (2014) pointed out that
much adaptive evolution probably occurred in regulatory, non-coding regions, but our results
indicate that genic variations may be more frequent in the human adaptive response to
pathogenic exposure. It is also important to point out that most studies identifying host genetic
resistance factors to pathogenic infection show one or a few SNVs functioning in an individual
manner. Our findings suggest that genetic variations in many genes may work in an integrated
and coordinated way, thus indicating polygenic selection.
It is noteworthy to state that our DT/ML selected-SNPs comprise a broad functional
panel. Type II C-type lectin (CLEC4C) is a transmembrane protein expressed selectively on
plasmacytoid dendritic cells. The triggering of the extra-cellular C-terminal C-type carbohydrate
recognition region of CLEC4C regulates the secretion of proinﬂammatory cytokines and type I
interferons (IFNs) (Lim et al. 2016), directly related with the oligoadenylate synthetase (OAS)
family. OAS proteins detect foreign RNA by oligoadenylate cytosolic PAMP (Pathogen Associated
Molecular Pattern), which leads to 2-5-oligoadenylate synthesis, which then acts as an
intracellular second messengers to activate latent ribonuclease L (RNase L). This activation
promotes indiscriminate cleavage of both host and viral RNA, and the production of additional

PAMPs, which reinforces the innate immune response (Schneider et al. 2014, Chakrabarti et al.
(2011). Upon stimulation, Toll-Like Receptors (TLRs) 7, 8, and 9 interact with the TIR domain of
MyD88 to recruit signaling molecules Interleukin-1 receptor-associated kinases (IRAK4/1/2) (He
et al. 2013). This recruitment leads to IkB degradation and thereby contributes to the activation
of NF-kB and MAPK signaling pathways to induce secretion of inﬂammatory cytokines, IFN type
I, chemokines, and antimicrobial peptides, and other innate immune response genes (He et al.
2013). Some of these genes have been previously related with dengue fever, such as CLEC4M,
OAS2,3, VEPH1 (Davi et al. 2019), CD209 (Tassaneetrithep et al. 2003), and Zika infection, such
as CD80, TLR7 (Hamel et al. 2015).
It is important to consider that the individual humans are “complex systems” programed
by billions of DNA base pairs. During evolution, DNA replication errors resulted in many
mutations across generations, and some favorable mutations became retained in the genome
as consequence of natural selection, contributing to population diversity. Here, our principal
message regarding host influences on CZS, beyond the immune genome gradient itself, is the
complexity of inter-individual and inter-population genetic backgrounds. We are proposing a
new theory to help explain the CZS catastrophe in Brazil. The hypothetical “human immune
genome complex gradient” is based on the host genetic population gene diversity produced by
human natural history and evolution across the world. Going forward, we propose that the
complexity of genetic data should be deeply analyzed using the most robust available
computational tools and a much broader immune genome SNV panel. Furthermore, ZIKV genetic
factors, environmental factors, and population immune history are essential in the modeling the
complex clinical phenotype of CZS Brazilian phenomenon.

METHODS

In order to examine the CZS phenomenon in Brazil from an evolutionary perspective,
we created a theoretical population immune genome in silico analysis. This method used a dual
computational approach: (i) a Decision Tree (DT) to select SNVs (features) as good population
discriminants and (ii) other machine learning models to improve the discrimination quality of
the selected SNV cluster. We assume theoretical (pooled, probably admixed) populations in this
approach. We consider sub-Saharan Africans, who evolved (probably) together with ZIKV, to be
naturally resistant; and we consider Latin Americans to be susceptible due to their historical
ZIKV naïve condition and the recent epidemics of CZS. As such, these two populations represent
the theoretical genetic extremes of CZS risk. In addition, we hypothesize that East Asians are
moderately susceptible.
Dataset characterization and preprocessing
The dataset was composed of genotype data from The 1000 Genomes Project (2015), and
included individuals from a mix of populations from three continents: the Americas, Africa, and
Asia (https://www.internationalgenome.org). The American population consisted of Mexicans
living in Los Angeles, United States (MXL), Puerto Ricans from Puerto Rico (PUR), Colombians
from Medellin (CLM) and Peruvians from Lima (PEL). The East Asian population was comprised
of Kinh from Ho Chi Minh City, Vietnam (KHV), Han Chinese from South China (CHS), Han Chinese
from Beijing (CHB), Chinese Dai from Xishuangbanna (CDX), and Japanese from Tokyo (JPT). The
African population was composed of Esan (ESN) and Yoruba (YRI) from Nigeria, Luhya from
Webuye, Kenya (LWK), Gambian Mandinka (GWD), Mende from Sierra Leone (MSL), and
descendants of Africans living in Barbados (ACB) and in the southwestern United States (ASW).
From each population, we selected 297 innate immune system SNVs previously interrogated in
a dengue genetic study (Davi et al. 2019). In total, the dataset comprised 297 attributes,
corresponding to 297 target SNVs and 1497 individuals: 661 Africans, 347 East Asians, and 489
Latin Americans. Dataset preprocessing was performed according to the following definitions:

(i) Each SNV was evaluated considering both alleles as a single point of information; (ii)
heterozygote information was homogenized (e.g. “A”/”C” and “C”/”A” were considered the
same); (iii) missing data were assigned the value NN. All attributes were categorical, containing
information about allelic pairs of each considered SNP - for example homozygotes such as AA,
or heterozygotes such as AT. For each SNP, each pair of alleles received an integer code. For
example, a given SNP containing allelic pairs AA, AT, and TT, was encoded as follows: AA = 1, AT
= 2, and TT =3. This integer encoding was done independently for each SNP.

Feature selection and classification
Decision Trees (DT) (Utgoff 1989) were used in the first step to reduce the prior set containing
297 SNVs to a smaller SNV dataset with a higher power for discrimination between sub-Saharan
Africans and Latin Americans. This was done to take advantage of the DT characteristic to
naturally select features that best discriminate classes, in this case distinct populations. In
addition, DTs make it possible to quantify and rank the importance of each attribute, which is
desirable for the subsequent biological analysis. Stratified 10-fold cross-validation was
performed as part of the feature selection effort. In this process, the dataset was divided into
ten parts of which nine were used as the training set and one part was used as the test set. This
procedure was repeated ten times, so that each pattern appeared only once as part of the test
set. Stratification occurred so that the proportion of individuals in each class in the training and
test sets was similar to the proportion of the dataset as a whole. After completing the ten
repetitions, the SNVs that were used by DT analysis in at least six of the ten repetitions were
considered as potentially good population discriminators and were selected to be used in the
second step by other classifier algorithms.
As the second step, the selected SNVs were evaluated regarding their discrimination quality.
Algorithms with wide acceptance in the literature were used: (i) logistic regression (LR) (Cox

1966), (ii) method of k nearest neighbors (KNN) (Cover 1967) and (iii) support vector machines
(Boser et al. 1992) with linear kernel (SVM-Linear) and with radial base function kernel (SVMRBF). Hence, we employed five dual DT/machine learning classification pipelines: DT/LR,
DT/KNN, DT/DT, DT/SVM-Linear, DT/SVM-RBF. The selected SNV set was evaluated using
holdout technique; accuracy and precision were calculated, and confusion matrixes and ROCCurves (correlation curve between Sensibility and 1-Specificity) for each model were generated.
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